BIO International Convention 2011 Schedule
Saturday Jun 25, 2011 |
|||
|---|---|---|---|
| Start | Duration | Session/Event | Where |
| 07:30AM | 07:30PM | BIO-LES Business Development Basics | |
| 08:30AM | 06:00PM | AURP Bio GreenTech Parks 2011 | Building: American Institute of Architects |
| 10:00AM | 03:00PM | U.S. National BioGENEius Challenge | Building: Omni Shoreham Hotel |
| 01:00PM | 06:00PM | Registration/Information & Housing Open |
Room: East Salon, Level 1 |
Sunday
|
|||
| Start | Duration | Session/Event | Where |
| 07:00AM | 06:00PM | Registration/Information & Housing Open |
Room: East Salon, Level 1 |
| 07:30AM | 04:00PM | BIO-LES Business Development Basics | |
| 08:00AM | 05:00PM | AURP Bio GreenTech Parks 2011 | Building: American Institute of Architects |
| 08:00AM | 06:30PM | Biotechnology Entrepreneurship Boot Camp | Room: 102 AB, Level 1 |
| 08:00AM | 05:00PM | 8th Annual Community College Program | |
| 08:30AM | 04:30PM | Biotech Primer: Biotech for the Non-Scientist |
|
| 04:00PM | 08:00PM | BIO Human Resources Conference 2011 | Building: Marriott Renaissance Hotel |
| 05:30PM | 08:30PM | International BioGENEius Challenge Awards Banquet |
Building: Omni Shoreham Hotel |
| 06:30PM | 07:30PM | Biotechnology Entrepreneurship Boot Camp Reception |
|
Monday
|
|||
| Start | Duration | Session/Event | Where |
| 07:00AM | 07:00PM | Registration/Information & Housing Open |
Room: East Salon, Level 1 |
| 07:00AM | 07:00PM | BIO Human Resources Conference 2011 | Building: Marriott Renaissance Hotel |
| 07:00AM | 07:00PM | International Lounge | Room: 150 Concourse |
| 07:30AM | 07:00PM | Partnering for Global Health (PGH) | |
| 07:30AM | 05:00PM | BIO-LES Business Development Basics | |
| 08:00AM | 04:00PM | BIO Golf Outing | Building: Mount Vernon Country Club |
| 08:15AM | 05:30PM | Biotechnology Entrepreneurship Boot Camp | Room: 102 AB, Level 1 |
| 08:30AM | 10:30AM | BIO 5K Run/Walk | Building: Washington & Old Dominion Trail, Arlington VA |
| 08:45AM | 05:00PM | Emerging Leaders Workshop: Hitting the Mark in New Product Commercialization |
Room: 144 A |
| 09:00AM | 05:00PM | BIO Executive Presentation Workshop | Room: 209BC, Level 2 |
| 09:00AM | 04:00PM | International BioGENEius Challenge | Room: 100 Concourse, Level 1 |
| 10:00AM | 12:00PM | Biotech Primer: Bio-Baffled? | Room: 150A, Level 1 |
| 12:00PM | 02:00PM | Diversity Summit | Building: Renaissance Washington DC Hotel; Marriott Renaissance Hotel |
| 01:00PM | 04:30PM | Leadership Summit: Deploying Agricultural and Industrial Biotechnologies to Meet Development Challenges |
Room: 143 AB |
| 01:00PM | 06:15PM | Translational Research Forum: Translational Medicine – A Global Endeavor |
Room: 145B, Level 1 |
| 02:00PM | 03:15PM | The Effect of a More Risk Averse Environment on Licensing Deals |
Room: 144 BC |
| 02:00PM | 03:15PM | Getting Approval for Drugs in an Ever-Increasing Risk-Averse World |
Room: 154 AB |
| 02:00PM | 03:15PM | Drug Patent Linkage and Compulsory Licensing – Challenges of Working Patented Inventions in India for Pharma Sector |
Room: 151 A |
| 02:00PM | 03:15PM | Crossing the Financing Gap? Alternative Strategies for Funding Biomedical Technologies for the Clinic |
Room: 149 AB |
| 02:00PM | 07:00PM | BIO Career Fair | Building: Grand Hyatt Washington |
| 02:00PM | 03:00PM | Diversity Summit Reception | Building: Marriott Renaissance Hotel; Renaissance Washington DC Hotel |
| 02:00PM | 03:15PM | Vaccines vs. Superbugs! The New Fight Against Hospital-Acquired Infections |
Room: 151B, Level 1 |
| 02:00PM | 03:15PM | Use of Imaging in Clinical Development: Risk Management Strategies for Site and Independent Image Evaluations |
Room: 152 A |
| 02:00PM | 02:45PM | Taiwan: Post ECFA Era-Opportunities for Global Biomedical Market |
Room: 152 B |
| 02:00PM | 03:15PM | Keys to Successful Orphan Drug Development: Three Case Studies |
Room: 150 A |
| 03:00PM | 03:45PM | Italy: Research in Space: A New Frontier for Biology and Medicine; The Biomedical Activities of Italian Space Agency (ASI). |
Room: 152 B |
| 03:45PM | 05:00PM | IP Issues Affecting Biomarker-Based Diagnostics |
Room: 152 A |
| 03:45PM | 05:00PM | M&A: Unique Risks and How Insurance Can Help Manage Some of Those Risks |
Room: 149 AB |
| 03:45PM | 05:00PM | Rare Disease Drug Development Goes Mainstream: What are the Regulatory Considerations? |
Room: 154 AB |
| 03:45PM | 05:00PM | The Vaccine Business Opportunity – Breakthrough Technologies for Preventing and Treating Disease |
Room: 151B, Level 1 |
| 03:45PM | 05:00PM | Disco Inferno – Pharma Feels the Heat With Discovery Deals |
Room: 144 BC |
| 03:45PM | 05:00PM | A Brave New World: Patent Litigation Tactics and Strategies for Biosimilars |
Room: 151 A |
| 03:45PM | 05:00PM | What Is the Future for Innovative Medicines in Our Industry’s Pipeline? |
Room: 150 A |
| 04:00PM | 04:45PM | Belgium: Funding Initiatives Boosting Biotech R&D |
Room: 147AB, Level 1 |
| 07:15PM | 09:00PM | Welcome Reception at the Newseum | Building: Newseum |
Tuesday
|
|||
| Start | Duration | Session/Event | Where |
| 07:00AM | 06:30PM | International Lounge | Room: 150 Concourse |
| 07:00AM | 06:30PM | Registration/Information & Housing Open |
Room: East Salon, Level 1 |
| 07:00AM | 04:00PM | BIO Human Resources Conference 2011 | Building: Marriott Renaissance Hotel |
| 08:00AM | 01:00PM | Biotechnology Entrepreneurship Boot Camp | Room: 102 AB, Level 1 |
| 08:00AM | 06:00PM | Business Forum Partnering Meeting Desk Open |
|
| 08:30AM | 09:45AM | Rediscovering the Promise of Biomarkers |
Room: 152 A |
| 08:30AM | 09:45AM | Optimizing the Review Process for Medical Countermeasures Requiring Use of the Animal Rule for Approval/Licensure |
Room: 154 AB |
| 08:30AM | 09:45AM | How Will We Afford Personalized Medicines? |
Room: 150 B |
| 08:30AM | 09:45AM | Creative Financing for the Next Generation of Blockbuster Biotechnologies |
Room: 149 AB |
| 08:30AM | 09:45AM | Patient Compliance and Market Opportunities: The Need for Half-life Extension |
Room: 156 |
| 08:30AM | 09:45AM | Belt-Tightening by the States: Impact of Health Reform and Deficit Control on Biotechnology Innovation |
Room: 143C, Level 1 |
| 08:30AM | 09:45AM | Better Living Through Biology – Synthetic Biology for Biofuel and Chemistry Production |
Room: 158 AB |
| 08:30AM | 09:45AM | International Regulation of Animal Biotechnology: A Discussion |
Room: 159 AB |
| 08:30AM | 09:45AM | Is the World Ready for the Next Pandemic Scare? A Look at Government and Industry Working Together |
Room: 152 B |
| 08:30AM | 09:15AM | Brazil: Bringing Innovation to Life through Partnerships with Academia, Industry & Government |
Room: 145B, Level 1 |
| 08:30AM | 09:45AM | De-risking the Phase II to Phase III Advancement Decision: Sound Science, Critical Thinking and Weighing Time vs. Cost |
Room: 150 A |
| 08:30AM | 09:45AM | The Partnering Conundrum: To Partner or Not to Partner, That Is the Question . . . |
Room: 144 BC |
| 08:30AM | 09:45AM | The Myriad Case and the Patentability of Isolated DNA Molecules |
Room: 151 A |
| 08:30AM | 09:45AM | The Pursuit of a Universal Influenza Vaccine? Where Are We Now, What Challenges Remain? |
Room: 151B, Level 1 |
| 08:45AM | 12:30PM | Emerging Leaders Workshop: Hitting the Mark in New Product Commercialization |
Room: 144 A |
| 09:00AM | 11:00AM | Business Forum Company Presentations | |
| 09:30AM | 10:15AM | Switzerland:Swiss Biotech - Innovative Platforms for Binding Protein Therapeutics |
Room: 145B, Level 1 |
| 09:30AM | 02:30PM | International BioGENEius Challenge | Room: 100 Concourse, Level 1 |
| 09:45AM | 10:00AM | BIO Exhibition Ribbon Cutting | Room: Exhibit Halls ABC, Level 2 |
| 10:00AM | 11:30AM | The Biomarkers Consortium: Facilitating the Development and Qualification of Biological Markers |
Room: 152 A |
| 10:00AM | 11:30AM | Collocation Strategies for Cellulosic Biofuel Production: Win-Win Scenarios Through Plant Integration |
Room: 158 AB |
| 10:00AM | 11:30AM | The Biomanufacturing Capacity Conundrum: Matching Supply and Demand Over Space and Time |
Room: 145A |
| 10:00AM | 11:30AM | Chasing Zero | Room: 159 AB |
| 10:00AM | 05:00PM | Business Forum Partnering | |
| 10:00AM | 11:30AM | Bioethics Roundtable | Room: 143 AB |
| 10:00AM | 06:30PM | BIO Pavilion | Room: L Street Bridge, Level 2 |
| 10:00AM | 06:30PM | BIO Patient & Health Advocacy Display |
Room: L Street Bridge, Level 2 |
| 10:00AM | 11:30AM | Ernst & Young’s 25th Annual Biotechnology Industry Report |
Room: 146 ABC, Level 1 |
| 10:00AM | 11:30AM | Patents in the Supreme Court | Room: 151 A |
| 10:00AM | 11:30AM | Financing Beyond the Lead Compound: Attracting Funding for Multiproduct Platforms |
Room: 149 AB |
| 10:00AM | 11:30AM | Addressing the Major Medical Challenges of Today with Personalized Medicine: Cancer,Diabetes and Brain Injury |
Room: 150 B |
| 10:00AM | 11:30AM | Navigating the New Law on Licensing Biosimilars |
Room: 154 AB |
| 10:00AM | 11:30AM | Going Global Overnight – Part II: Building Sustainable Investment in Emerging Markets |
Room: 152 B |
| 10:00AM | 11:30AM | Navigating New Trends in the Industry: How Pharma and Biotech Collaborations Are Shaping the Future of Drug Development |
Room: 144 BC |
| 10:00AM | 06:30PM | BIO Exhibition Open | Room: Exhibit Halls ABC, Level 2 |
| 10:00AM | 11:30AM | “Common Needs” and Uncommon Cooperation: The State of Joint FDA and CMS Initiatives |
Room: 143C, Level 1 |
| 10:00AM | 11:30AM | Therapeutic and Prophylactic Approaches for the Treatment of HSV-2 Infection |
Room: 151B, Level 1 |
| 10:00AM | 11:30AM | The Road to Commercialization: What Role Can the Patient Community Play? |
Room: 150 A |
| 10:30AM | 11:15AM | Mexico: Commercialization of Biotechnology Research in Mexico |
Room: 145B, Level 1 |
| 12:00PM | 02:00PM | Tuesday Keynote Luncheon: An Interview with Tony Blair |
Room: Level 3, Ballroom |
| 02:00PM | 03:30PM | Capitol Hill Trumps Wall Street? Finding the Harmony in Biorenewable R&D |
Room: 158 AB |
| 02:00PM | 03:30PM | Wait, Our Model Isn’t Dead! We Just Need to Evolve |
Room: 149 AB |
| 02:00PM | 02:45PM | Cuban Biotechnology: An Overview of Cuba’s Drug and Vaccine Developments and Innovations |
Room: 145B, Level 1 |
| 02:00PM | 03:30PM | Looking Beyond Row Crops: What’s Next for Agricultural Biotechnology? |
Room: 159 AB |
| 02:00PM | 03:30PM | Rare Diseases Experience as a Model to Critically Affect Innovation in Biomarker Strategy and Precision Medicine |
Room: 145A |
| 02:00PM | 03:30PM | Attacking the Next Biomanufacturing Bottleneck: Downstream Processing |
Room: 156 |
| 02:00PM | 03:30PM | Therapeutic Cancer DNA Vaccines: Advances in Technologies, Advances Clinical Success |
Room: 151B, Level 1 |
| 02:00PM | 03:30PM | NIH’s Best Kept Secret: Widely Available Research Resources |
Room: 150 A |
| 02:00PM | 03:30PM | How Will Congress Act on Upcoming PDUFA Reauthorization |
Room: 154 AB |
| 02:00PM | 03:30PM | Counterfeiting – How Corporations and the Government Can Work Together |
Room: 151 A |
| 02:00PM | 03:30PM | Personalized Oncology: The Emergence of Personalized Medicine Strategies in Oncology Clinical Development and Deal Making |
Room: 150 B |
| 02:00PM | 03:30PM | Burrill State-of-the-Industry Report | Room: 146 ABC, Level 1 |
| 02:00PM | 04:00PM | Business Forum Company Presentations | |
| 02:00PM | 03:30PM | EU/US Cooperation to Support Research on Rare Diseases |
Room: 152 B |
| 02:00PM | 03:30PM | The Changing BD Environment: Overcoming Our Past to Succeed in the Future |
Room: 144 BC |
| 02:00PM | 03:30PM | Current Challenges in Payment System Reform |
Room: 143C, Level 1 |
| 02:15PM | 02:45PM | Off-shoring Versus Near-shoring: Why This Question No Longer has an Easy Answer |
|
| 02:50PM | 03:20PM | A New Clinical Operations Model: Proactive Planning at Work |
|
| 03:00PM | 03:45PM | United Kingdom: Bench, Bed and Beyond: A Vertically-Integrated Approach to Healthcare R&D and Delivery |
Room: 145B, Level 1 |
| 03:25PM | 03:55PM | Getting into the Clinical Research Game: How Investigative Sites Can Best Market Themselves to Sponsors and CROs |
|
| 03:45PM | 05:00PM | Drug Safety for Imported Drug Products | Room: 156 |
| 03:45PM | 05:00PM | Ignoring the Speed Limit: Can New Approaches Truly Affect How Fast Drugs Get to Market? |
Room: 145A |
| 03:45PM | 05:00PM | Talking About Your Product in the New Age: Social Media and the Internet |
Room: 154 AB |
| 03:45PM | 05:15PM | It Takes a Village – The Biotechnology Innovation Ecosystem |
Room: Level 1, 147 AB |
| 03:45PM | 05:00PM | Closing the Funding Gap in India for Commercialization of Biotechnology: Moving From Possibility to Opportunity |
Room: 152 B |
| 03:45PM | 05:00PM | Personalized Medicine and Already Approved Drugs: The Plavix Case Study and What You Don’t Know Can Hurt You |
Room: 150 B |
| 03:45PM | 05:00PM | The Evolving Business Model for Biomarkers: Status and Future Perspectives |
Room: 152 A |
| 03:45PM | 05:00PM | Is Something Wrong With Our Alliance?: How to Find Out Quickly |
Room: 144 BC |
| 03:45PM | 05:00PM | Markets for Dual-Use Energy Crops | Room: 158 AB |
| 03:45PM | 05:00PM | From Evidence to Practice: The Impact of Comparative Effectiveness Research on the Physician-Patient Relationship |
Room: 143C, Level 1 |
| 03:45PM | 05:00PM | Managing the Capital Agenda Toward a Patient-Centric Future |
Room: 149 AB |
| 03:45PM | 05:00PM | Excellence Through Stewardship (ETS): The value of Quality Management Systems (QMS) to Plant Biotechnology |
Room: 159 AB |
| 04:00PM | 04:30PM | How has Financial Market Turbulence Affected the Contract Research Industry? |
|
| 04:00PM | 04:45PM | Russia: Launching Innovation: Russia’s Bio-Infrastructure and Life Sciences Sector |
Room: 145B, Level 1 |
| 04:30PM | 05:00PM | Producing Complex Proteins in Plant Based Systems as an Alternative Expression System |
|
| 05:00PM | 06:30PM | BIO Exhibitor Hospitality Receptions | Room: Exhibit Halls ABC, Level 2 |
Wednesday
|
|||
| Start | Duration | Session/Event | Where |
| 07:00AM | 05:30PM | Business Forum Partnering Meeting Desk Open |
|
| 08:00AM | 05:00PM | Business Forum Partnering | |
| 08:00AM | 05:00PM | International Lounge | Room: 150 Concourse |
| 08:00AM | 05:00PM | Registration/Information & Housing Open |
Room: East Salon, Level 1 |
| 08:15AM | 06:00PM | 2011 Biosecurity Conference | Room: 143 AB |
| 08:30AM | 09:45AM | From Direct Solar to Drop-Ins: The Next Wave in Biofuels Technologies |
Room: 158 AB |
| 08:30AM | 09:45AM | Secrets of the Big Pharma Dealmaker | Room: 144 BC |
| 08:30AM | 09:45AM | Russian Biopharma: At the Edge of Ambitious “Pharma2020″ Governmental Program |
Room: 152 B |
| 08:30AM | 09:45AM | Vaccines and Healthcare Reform: Opportunities for Growth |
Room: 151B, Level 1 |
| 08:30AM | 09:45AM | Funding to NDA – New Strategies in Private Financing |
Room: 145A |
| 08:30AM | 09:45AM | Strategic Commercialization for Molecular Diagnostic Tests |
Room: 150 B |
| 08:30AM | 09:45AM | A Look Into the Future of Animal Biotechnology |
Room: 159 AB |
| 08:30AM | 09:45AM | Opening Keynote Address: A View from the Hill |
Room: 143 AB |
| 08:30AM | 09:45AM | Diabetes Forum: Preventive and Therapeutic Diabetes Vaccines |
Room: 209BC, Level 2 |
| 08:30AM | 09:45AM | A Bittersweet Crossroad? Embarking on the Path to Developing Novel Diabetes Therapies. |
Room: 150 A |
| 08:30AM | 09:45AM | Innovative Marketing and Technology Transfer – Federal Agencies Have Joined the Game |
Room: 151 A |
| 08:30AM | 09:15AM | India: Indian Biotech Industry: Potential Innovator, Collaborator and Partner for Global Health Care |
Room: 145B, Level 1 |
| 08:30AM | 06:00PM | Diabetes Forum – Emerging Strategies, Challenges & Partnerships |
Room: 209BC, Level 2 |
| 08:30AM | 09:45AM | Lessons From a Mature Public-Private Partnership: The Alzheimer’s Disease Neuroimaging Initiative |
Room: 152 A |
| 09:00AM | 11:00AM | Business Forum Company Presentations | |
| 09:30AM | 10:15AM | Spain’s R&D Facilities, the Driving Force of an Innovation Ecosystem |
Room: 145B, Level 1 |
| 09:45AM | 11:15AM | Improving Global Bio-surveillance | Room: 143 AB |
| 10:00AM | 11:30AM | EMA/FDA Town Hall | Room: 154 AB |
| 10:00AM | 11:30AM | Emerging Markets: The Future of Growth for Biologics? |
Room: Level 1, 147 AB |
| 10:00AM | 05:00PM | BIO Patient & Health Advocacy Display |
Room: L Street Bridge, Level 2 |
| 10:00AM | 05:00PM | BIO Pavilion | Room: L Street Bridge, Level 2 |
| 10:00AM | 11:30AM | From “Made in China” to “Discovered in China” ? Challenges and Opportunities |
Room: 152 B |
| 10:00AM | 11:30AM | Diabetes Forum: Diabetes – The Disease of the Decade: Epidemiology, Economics, Emerging Strategies |
Room: 209BC, Level 2 |
| 10:00AM | 11:30AM | Progress of Research in Bioenergy Centers: An Update on the Major DOE and Other Bioenergy Research Centers |
Room: 158 AB |
| 10:00AM | 11:30AM | Are Diagnostic Reimbursement Policies Impeding Personalized Medicine? |
Room: 150 B |
| 10:00AM | 11:30AM | Getting a Biotech Crop to Market — How Much, How Long, and What Steps? |
Room: 159 AB |
| 10:00AM | 11:30AM | Premature or Prescient? When Big Pharma Is Doing Preclinical Deals With Seemingly Clinical-Stage Valuations |
Room: 144 BC |
| 10:00AM | 11:30AM | Starting Up Biotechs in the New Normal World |
Room: 149 AB |
| 10:00AM | 11:30AM | Looking to the Future: Innovative Approaches to HIV Vaccine Development and Immunotherapies |
Room: 151B, Level 1 |
| 10:00AM | 11:30AM | Lessons From In-Licensing Partnership: Biotech Company Partners With Global Pharma to Deliver Cutting-Edge Biosimilars |
Room: 151 A |
| 10:00AM | 11:30AM | The Role of Imaging Biomarkers in Early Clinical Phase CNS Drug Development |
Room: 152 A |
| 10:00AM | 05:00PM | BIO Exhibition Open | Room: Exhibit Halls ABC, Level 2 |
| 10:30AM | 11:15AM | Korea: Licensing & Business Development in Korea: Emerging Market Strategy in the New Decade |
Room: 145B, Level 1 |
| 12:00PM | 02:00PM | Wednesday Keynote Luncheon | Room: Level 3, Ballroom |
| 02:00PM | 03:30PM | Stratified Medicine – Hype or Hope | Room: 152 A |
| 02:00PM | 03:30PM | Campbell Alliance 2011 Dealmakers’ Intentions |
Room: Level 1, 147 AB |
| 02:00PM | 03:30PM | Countering Counterfeiting | Room: 145A |
| 02:00PM | 03:30PM | Managing Global Challenges in an Evolving Threat Environment |
Room: 143 AB |
| 02:00PM | 03:30PM | Diabetes Forum: Alternative Financing of Transformative Therapies for Diabetes |
Room: 209BC, Level 2 |
| 02:00PM | 03:30PM | New Technologies for Sustainable Crop Production |
Room: 159 AB |
| 02:00PM | 03:30PM | Collaborative R&D From the Perspective of Large Multinationals, Universities and Start-ups |
Room: 151 A |
| 02:00PM | 03:30PM | IP Challenges for Personalized Medicine: Navigating Bilski, Myriad, and Prometheus |
Room: 150 B |
| 02:00PM | 03:30PM | Views From the Top: Executive Perspectives on Key Policy Issues Facing the Biopharmacutical Industry |
Room: 143C, Level 1 |
| 02:00PM | 04:00PM | Business Forum Company Presentations | |
| 02:00PM | 03:30PM | Collaborations and Strategies to Crossing the Valley of Death to Fund Innovative Medicines |
Room: 149 AB |
| 02:00PM | 02:45PM | Saudi Arabia: BioMed Technology: Industry Competitiveness of Saudi Arabia |
Room: 145B, Level 1 |
| 02:00PM | 03:30PM | FDA – Town Hall | Room: 154 AB |
| 02:00PM | 03:30PM | The Promise of MicroRNA-Based Therapeutics in Cancer |
Room: 150 A |
| 02:00PM | 03:30PM | Moving to the Next Level: Accessing Capital Internationally |
Room: 144 BC |
| 03:00PM | 03:45PM | Israel: Creating Biomedical Innovation in Israel: Reciprocal Relationship of University, Industry and Government |
Room: 145B, Level 1 |
| 03:45PM | 05:00PM | Successes and Challenges in Public-Private Partnerships |
Room: 143 AB |
| 03:45PM | 05:00PM | Diabetes Forum: Biomarkers and Diagnostics for Type 1 and Type 2 Diabetes: The Frontier of Personalized Medicine |
Room: 209BC, Level 2 |
| 03:45PM | 05:00PM | BIO Exhibition Power Hours | |
| 03:45PM | 05:15PM | Worldview 2011: Scientific American’s Regional Bio-Innovation Scorecard |
Room: 146BC, Level 1 |
| 04:00PM | 04:45PM | France: Vaccine Innovation, a Collaborative Approach: from Diagnosis to Prevention and Treatment |
Room: 145B, Level 1 |
| 05:00PM | 06:30PM | Think & Drink Discussion Forum: Innovation Politics – From Capitol Hill to the Campaign Trail |
Room: Grand Lobby, Level 1 |
| 05:00PM | 06:00PM | Business Forum Wine and Cheese Reception | |
| 05:15PM | 06:15PM | International Reception | Room: 146A, Level 1 |
| 07:45PM | 09:30PM | Gala Reception at Union Station |
Building: Union Station |
Thursday
|
|||
| Start | Duration | Session/Event | Where |
| 07:00AM | 05:30PM | Business Forum Partnering Meeting Desk Open |
|
| 08:00AM | 02:30PM | International Lounge | Room: 150 Concourse |
| 08:00AM | 02:30PM | Registration/Information & Housing Open |
Room: East Salon, Level 1 |
| 08:00AM | 05:00PM | Business Forum Partnering | |
| 08:15AM | 09:45AM | Financing Biodefense as a National Security Priority |
Room: 143 AB |
| 08:30AM | 02:00PM | 2011 Biosecurity Conference | Room: 143 AB |
| 08:30AM | 09:45AM | Scientific and Regulatory Implications of Changes to ICH S6 for Design and Conduct of Nonclinical Safety Evaluation Programs for Biopharmaceuticals |
Room: 150 A |
| 08:30AM | 09:45AM | Personalized Medicine and Companion Diagnostics: The Changing Biopharma Industry Landscape |
Room: 150 B |
| 08:30AM | 09:45AM | Biologics & Biosimilars: What is the Science Telling Us? |
Room: 154 AB |
| 08:30AM | 09:45AM | Safer, Faster, Cheaper: Changing Process Paradigms, Platforms and Products in Biomanufacturing |
Room: 156 |
| 08:30AM | 09:45AM | After the Fall: Venture Capital and the Biotech Funding Landscape |
Room: 149 AB |
| 08:30AM | 09:45AM | White Biotechnology: From Laboratory to Demonstration Scale |
Room: 158 AB |
| 08:30AM | 09:45AM | Innovative Collaborations: Deal Structures for Nonprofit/For-Profit Collaborations |
Room: 151 A |
| 08:30AM | 09:45AM | Improving Innovation Through the use of Social Networks |
Room: 152 B |
| 08:30AM | 11:00AM | Diabetes Forum – Emerging Strategies, Challenges & Partnerships |
Room: 209BC, Level 2 |
| 08:30AM | 09:45AM | Diabetes Forum: Cell-Based Therapies for Diabetes: Opportunities and Challenges |
Room: 209BC, Level 2 |
| 08:30AM | 09:45AM | Accelerating Product Development With Nondilutive Funding for Private Biotechs |
Room: 144 BC |
| 08:30AM | 09:15AM | European Commission: European Innovation Union: Fostering Innovations in the Healthcare Industry |
Room: 145B, Level 1 |
| 08:30AM | 09:45AM | Experimental Field Trials With Biotech Corn and Conservation of Corn Landraces in Mexico |
Room: 145A |
| 09:00AM | 11:00AM | Business Forum Company Presentations | |
| 09:30AM | 10:15AM | Japan: Japan’s Regulatory Reform and Open Innovation Policy: Assisting Global Development of Innovative Drugs |
Room: 145B, Level 1 |
| 09:45AM | 11:15AM | Protecting the Unprotected: Countermeasures for At-Risk and Vulnerable Populations |
Room: 143 AB |
| 10:00AM | 02:00PM | BIO Exhibition Open | Room: Exhibit Halls ABC, Level 2 |
| 10:00AM | 11:30AM | Success in the States: A Guide for Foreign Companies to the Largest Venture Capital Pool in the World |
Room: 149 AB |
| 10:00AM | 11:30AM | Environmental Review of GE Food and Agriculture Products |
Room: 159 AB |
| 10:00AM | 11:30AM | How Dare They Dope With Our Medicines? | Room: 156 |
| 10:00AM | 11:30AM | Advanced Molecular Diagnostics: Reforming Regulation and Reimbursement |
Room: 143C, Level 1 |
| 10:00AM | 11:30AM | New Opportunities for Investment in Europe: Industry and Research Policy Environments for All Biotech Sectors |
Room: 145A |
| 10:00AM | 11:30AM | Relationship Management: An Essential Key Enabler for Alliance Success |
Room: 144 BC |
| 10:00AM | 11:30AM | Diabetes Forum: The Next Frontier for Glucose Control in Diabetes: Devices: Closed Loop Artificial Pancreas and Drugs: Glucose-Responsive Insulins |
Room: 209BC, Level 2 |
| 10:00AM | 11:30AM | Protecting your Biotech IP in Europe - one of the largest markets in the world. |
Room: 151 A |
| 10:00AM | 02:00PM | BIO Patient & Health Advocacy Display |
Room: L Street Bridge, Level 2 |
| 10:00AM | 11:30AM | Regulatory Issues for Tissue Engineered Products |
Room: 154 AB |
| 10:00AM | 02:00PM | BIO Pavilion | Room: L Street Bridge, Level 2 |
| 10:30AM | 11:15AM | China: International Cooperation Opportunities in a Resourceful China |
Room: 145B, Level 1 |
| 11:30AM | 02:00PM | BIO Exhibition Power Hours | Room: Exhibit Halls ABC, Level 2 |
| 11:30AM | 01:00PM | Managing Technological Innovation in the New Era |
Room: 143 AB |
| 01:30PM | 02:00PM | Closing Keynote Address: “The Role of the BWC in a Biotech-Driven World” |
Room: 143 AB |